MMR

Indications: Vaccination provides protection against measles, mumps and rubella infections.

Vaccination: It is given to children as injection at 13 months of age followed up with a second vaccination for children of school age. If vaccination was done before 1980 a revaccination is recommended before travelling.

Protection: After revaccination protection is lifelong.

Side effects include:

• Local tenderness at the injection site
• Mild fever
• Occasionally, convulsions.

MMR Vaccination Resource:

[Assessment of primary care physicians' adherence to the national childhood vaccination schedule.]
Pruvost I, Lowingerova-Fauvet S, Debacker P, Dervaux B, Dubos F, Martinot A.
Arch Pediatr. 2012 Jan 18. [Epub ahead of print] French.
Mumps vaccine effectiveness against orchitis.
Hahné S, Whelan J, van Binnendijk R, Swaan C, Fanoy E, Boot H, de Melker H.
Emerg Infect Dis. 2012 Jan;18(1):191-3. doi: 10.3201/eid1801.111178
Associations Between Demographic Variables and Multiple Measles-Specific Innate and Cell-Mediated Immune Responses After Measles Vaccination.
Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, Poland GA.
Viral Immunol. 2012 Jan 12. [Epub ahead of print
The Blame Frame: Media Attribution of Culpability About the MMR-Autism Vaccination Scare.
Holton A, Weberling B, Clarke CE, Smith MJ.
Health Commun. 2012 Jan 11. [Epub ahead of print
The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R.
Pediatrics. 2012 Feb;129(2):248-55. Epub 2012 Jan 9
Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations.
Moreno-Pérez D, Alvarez García FJ, Aristegui Fernández J, Barrio Corrales F, Cilleruelo Ortega MJ, Corretger Rauet JM, González-Hachero J, Hernández-Sampelayo Matos T, Merino Moína M, Ortigosa Del Castillo L, Ruiz-Contreras J; on behalf of the Advisory Committee on Vaccines of the Spanish Association of Pediatrics.
An Pediatr (Barc). 2012 Jan;76(1):43.e1-43.e23. Epub 2011 Dec 16
[Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations].
Moreno-Pérez D, Alvarez García FJ, Arístegui Fernández J, Barrio Corrales F, Cilleruelo Ortega MJ, Corretger Rauet JM, González-Hachero J, Hernández-Sampelayo Matos T, Merino Moína M, Ortigosa Del Castillo L, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría.
An Pediatr (Barc). 2012 Jan;76(1):42.e1-42.e23. Epub 2011 Dec 16. Spanish.
Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis.
Wilson K, Hawken S, Kwong JC, Deeks S, Crowcroft NS, Van Walraven C, Potter BK, Chakraborty P, Keelan J, Pluscauskas M, Manuel D.
PLoS One. 2011;6(12):e27897. Epub 2011 Dec 12
Similarity of parents and physicians in the decision to vaccinate children against measles, mumps and rubella.
Kriwy P.
Int J Public Health. 2011 Dec 16. [Epub ahead of print
[Susceptibility to measles and varicella in healthcare workers in a tertiary hospital in Catalonia.]
Fernández-Cano MI, Armadans L, Sulleiro E, Espuga M, Ferrer E, Martínez-Gómez X, Vaqué J, Campins M.
Enferm Infecc Microbiol Clin. 2011 Nov 30. [Epub ahead of print] Spanish.
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, Iannilli A, d'Annunzio G, Iafusco D, Songini M, Toni S, Cherubini V, Carle F; RIDI Study Group..
Diabet Med. 2011 Dec 1. doi: 10.1111/j.1464-5491.2011.03529.x. [Epub ahead of print
Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
Paranthaman K, Bunce A.
Epidemiol Infect. 2011 Nov 25:1-5. [Epub ahead of print
A game dynamic model for vaccine skeptics and vaccine believers: Measles as an example.
Shim E, Grefenstette JJ, Albert SM, Cakouros BE, Burke DS.
J Theor Biol. 2012 Feb 21;295:194-203. Epub 2011 Nov 15
Acceptance on the move: Public reaction to shifting vaccination realities.
Velan B.
Hum Vaccin. 2011 Dec;7(12):1261-70. Epub 2011 Dec 1
[Pityriasis rubra pilaris after vaccination].
Naciri Bennani B, Cheikh Rouhou H, Waton J, Cuny JF, Bassegoda G, Trechot P, Barbaud A, Schmutz JL.
Ann Dermatol Venereol. 2011 Nov;138(11):753-6. Epub 2011 Sep 9. French.
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008.
Duderstadt SK, Rose CE Jr, Real TM, Sabatier JF, Stewart B, Ma G, Yerubandi UD, Eick AA, Tokars JI, McNeil MM.
Vaccine. 2012 Jan 17;30(4):813-9. Epub 2011 Nov 8
Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study.
Avijgan M, Hafizi M, Moghni M, Kheiri S, Esteghamati A, Sarikhani S.
East Afr J Public Health. 2011 Jun;8(2):88-91
An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.
Klein NP, Weston WM, Kuriyakose S, Kolhe D, Howe B, Friedland LR, Van Der Meeren O.
Vaccine. 2012 Jan 11;30(3):668-74. Epub 2011 Nov 4
Lessons from an online debate about measles-mumps-rubella (MMR) immunization.
Nicholson MS, Leask J.
Vaccine. 2011 Nov 7. [Epub ahead of print
A case of lichen planus following Tdap vaccination.
Ghasri P, Roehmholdt BF, Young LC.
J Drugs Dermatol. 2011 Sep 1;10(9):1067-9
First 1 2 3 4 5 6 7 8 9 Next Last 47/923 Jump: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47

To top Back to list of vaccination• Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster